NeuroSense Therapeutics Ltd. (NASDAQ:NRSNW – Get Free Report) was the recipient of a significant decline in short interest in September. As of September 30th, there was short interest totalling 500 shares, a decline of 28.6% from the September 15th total of 700 shares. Based on an average daily trading volume, of 1,800 shares, the days-to-cover ratio is presently 0.3 days.
NeuroSense Therapeutics Price Performance
NRSNW remained flat at $0.12 on Friday. 7 shares of the company were exchanged, compared to its average volume of 8,805. NeuroSense Therapeutics has a one year low of $0.07 and a one year high of $0.65. The firm has a 50 day moving average price of $0.16 and a two-hundred day moving average price of $0.20.
NeuroSense Therapeutics Company Profile
Featured Stories
- Five stocks we like better than NeuroSense Therapeutics
- Buy P&G Now, Before It Sets A New All-Time High
- 3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- China’s EV Rally: Should Investors Chase, Avoid, or Buy the Dip?
- Stock Average Calculator
- MarketBeat Week in Review – 10/7 – 10/11
Receive News & Ratings for NeuroSense Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeuroSense Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.